Abstract
We are pleased to announce the exciting news that SAGE Publishing, Inc. is now the new publisher of Cell Transplantation.
As SAGE’s medical publishing portfolio has continued to grow, they took notice of the potential of our journal and approached us regarding their vision for the continued development of this publication. We feel the advantages of working with SAGE are numerous, and we expect this change will result in expansion of the global reach and impact of the journal.
Shinn-Zong (John) Lin and Paul R. Sanberg are pleased to have been asked to remain on as Co-Editors-in-Chief of Cell Transplantation, and we expect that there will be no delay in the publication schedule. The Editorial Board will remain essentially the same, including Samantha Portis as Managing Editor (previously Associate Editor). We’re also pleased to welcome our new editorial assistant, Kuan-I (Josephine) Lin from Taiwan. Currently, all submission, editorial, and review processes will remain the same. SAGE will continue to work with the Manuscript Central site, and all published content will remain on IngentaConnect through the end of 2017.
On behalf of all who have been involved with Cell Transplantation since its inception in 1992, we would like to acknowledge Cognizant Communication Corporation for recognizing the journal’s potential over 26 years ago and for their devotion, development, hard work, and experience, which has enabled us to bring this publication to the recognition and success it celebrates today. We thank Cognizant for recognizing that with SAGE’s long-term vision for this publication, there is no limit to what can be achieved.
Cognizant remains strong in the publishing industry and continues to undertake new projects for development. We wish them luck in all their endeavors.
We would like to express our sincere gratitude to our readers, authors, and reviewers for their continued dedication and support. As we move forward, we are looking for new reviewers and potential editorial board members, as well as new ideas on submissions of important articles or themed issues within the field of cell transplantation and regenerative medicine. We look forward to your continued collaboration with us as we embark on this exciting new chapter for Cell Transplantation.